Analyzing the clinical actionability of germline pharmacogenomic findings in oncology
Sign Up to like & getrecommendations! Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31382
Abstract: Germline and tumor pharmacogenomics impact drug responses, but germline markers less commonly guide oncology prescribing. The authors hypothesized that a critical number of clinically actionable germline pharmacogenomic associations exist, representing clinical implementation opportunities. read more here.
Keywords: analyzing clinical; germline pharmacogenomic; actionability germline; pharmacogenomic findings ... See more keywords
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34104
Abstract: In recent years, there has been increasing evidence supporting the role of germline pharmacogenomic factors predicting toxicity for anticancer therapies. Although somatic genomic data are used frequently in oncology care planning, germline pharmacogenomic testing is… read more here.
Keywords: actionable genotypes; clinically actionable; pharmacogenomic testing; genotypes anticancer ... See more keywords